Related Experiment Video

Updated: Dec 5, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.3K

GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma

Amanda R Moore, Leili Ran, Youxin Guan

    Cell Reports
    |October 14, 2020
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
    08:18

    Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

    Published on: September 8, 2021

    3.2K
    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
    08:57

    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

    Published on: May 17, 2024

    2.3K

    Related Experiment Videos

    Last Updated: Dec 5, 2025

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
    06:09

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

    Published on: June 7, 2019

    9.3K
    Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
    08:18

    Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

    Published on: September 8, 2021

    3.2K
    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
    08:57

    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

    Published on: May 17, 2024

    2.3K

    Related Concept Videos

    Small GTPases - Ras and Rho01:24

    Small GTPases - Ras and Rho

    4.9K
    Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
    Three regulatory proteins control their activity:
    4.9K
    Mouse Models of Cancer Study02:43

    Mouse Models of Cancer Study

    6.2K
    Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
    The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
    6.2K
    The Ras Gene02:38

    The Ras Gene

    6.8K
    The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
    Ras is a...
    6.8K

    Articles linked to this work by shared authors, journal, and citation graph.

    Comprehensive Genomic Characterization of Primary Dermal Melanoma: Delineating it from Metastatic Melanoma with Unknown Primary.

    Human pathology·2026

    Universal Germline Genetic Testing after a Diagnosis of Cancer.

    Cancer discovery·2026

    Treatment patterns and outcomes in advanced clear cell sarcoma and gastrointestinal neuroectodermal tumors.

    JNCI cancer spectrum·2026

    Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.

    European journal of cancer (Oxford, England : 1990)·2026

    Outpatient Treatment-Related Toxicity After Hospital Discharge Among Patients Receiving Lifileucel for Advanced Melanoma.

    JCO oncology practice·2026

    Molecular Alterations in Patients of Color with Advanced Cutaneous and Unknown Primary Melanomas.

    Journal of the American Academy of Dermatology·2026

    Inferring binding specificities of human transcription factors with the wisdom of crowds.

    Cell reports·2026

    SNX17 facilitates entry and infection of Rift Valley fever virus and related bunyaviruses.

    Cell reports·2026

    Sorafenib enhances graft-versus-leukemia activity through IL-18-mediated macrophage and NK cell crosstalk in FLT3-ITD acute myeloid leukemia.

    Cell reports·2026

    Functional identification of non-coding regulatory regions that drive breast and skin carcinogenesis.

    Cell reports·2026

    Mechanical compression activates cAMP signaling in Pseudomonas aeruginosa.

    Cell reports·2026

    Host-triggered prophage induction drives Lactiplantibacillus plantarum symbiosis through bacterial lysis.

    Cell reports·2026

    Targeting KIT and PDGFRA mutations in advanced gist: current and future clinical implications.

    Expert review of anticancer therapy·2026

    Biomaterial-Based Controlled Release Systems for Spinal Cord Remyelination.

    Advanced materials (Deerfield Beach, Fla.)·2026

    Molecular mechanism of Xanthotoxol against gastric cancer: A comprehensive study integrating network pharmacology, computer simulations, and experimental validation.

    Animal models and experimental medicine·2026

    ZNF865 (BLST) a Novel Regulator of DNA Damage and Cell Senescence in Back Pain.

    Aging cell·2026

    Contributions of the anion exchangers SLC26A1, SLC26A2, SLC26A3, and SLC26A6 to intestinal oxalate transport in human Caco2-BBE cells.

    Physiological reports·2026

    [Chinese expert consensus on the management of corneal and ocular surface adverse events related to antibody-drug conjugates (2026)].

    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us